Skip to content

Author

H. Direşkeneli

We have 2 of 710 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Feb 2026

Serum advanced glycation end products and glyoxalase-1 levels in Behçet's disease: a cross-sectional study.

OBJECTIVES Behçet's disease (BD) is a chronic, systemic inflammatory disorder. Despite the presence of chronic inflammation in BD, a clear increase in atherosclerotic cardiovascular mortality has not been documented. However, chronic inflammation may contribute to atherogenesis through various pathways, including accel...

Tuba Kaplan, Zeynep Tüzün, Tülin Ergun et al. · 0 citations
Open access Feb 2026

PD-1 on CD8+T cells are low in Behçet's disease and is not normalised with type-I interferon.

The decreased PD-1 expression on CD8+T cells, along with the decreased PD-1, TIM-3 and TIGIT responses of CD8+T cells upon IFN-I stimulation, demonstrated an altered immune response in Behçet's disease.

Selda Bilgin, Tuba Kaplan, R. Deniz et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.